BioPharma Dive 1. Mai 2026 Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook
BioPharma Dive 30. Apr. 2026 UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy
BioPharma Dive 29. Apr. 2026 FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech